These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35287144)

  • 1. Identification of Immunoglobulin G Autoantibody Against Malondialdehyde-Acetaldehyde Adducts as a Novel Serological Biomarker for Ulcerative Colitis.
    Duryee MJ; Ahmad R; Eichele DD; Hunter CD; Mitra A; Talmon GA; Singh S; Smith LM; Rosen MJ; Dhawan P; Thiele GM; Singh AB
    Clin Transl Gastroenterol; 2022 Apr; 13(4):e00469. PubMed ID: 35287144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological profiling of Crohn's disease and ulcerative colitis patients reveals anti-microbial antibody signatures.
    Shome M; Song L; Williams S; Chung Y; Murugan V; Park JG; Faubion W; Pasha SF; Leighton JA; LaBaer J; Qiu J
    World J Gastroenterol; 2022 Aug; 28(30):4089-4101. PubMed ID: 36157118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Location-based prediction model for Crohn's disease regarding a novel serological marker, anti-chitinase 3-like 1 autoantibodies.
    Sipeki N; Kovats PJ; Deutschmann C; Schierack P; Roggenbuck D; Papp M
    World J Gastroenterol; 2023 Nov; 29(42):5728-5750. PubMed ID: 38075846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis.
    Thiele GM; Duryee MJ; Anderson DR; Klassen LW; Mohring SM; Young KA; Benissan-Messan D; Sayles H; Dusad A; Hunter CD; Sokolove J; Robinson WH; O'Dell JR; Nicholas AP; Tuma DJ; Mikuls TR
    Arthritis Rheumatol; 2015 Mar; 67(3):645-55. PubMed ID: 25417811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
    Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
    J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic utility, disease activity, and disease phenotype correlation of serum ASCA, pANCA, and PR3-ANCA in pediatric inflammatory bowel disease.
    Kim JM; Choi YM; Jung SA; Yang HR
    J Pediatr (Rio J); 2024; 100(2):204-211. PubMed ID: 38012956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease.
    Rolla R; Vay D; Mottaran E; Parodi M; Traverso N; Aricó S; Sartori M; Bellomo G; Klassen LW; Thiele GM; Tuma DJ; Albano E
    Hepatology; 2000 Apr; 31(4):878-84. PubMed ID: 10733543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of anti-integrin αvβ6 antibodies in ulcerative colitis.
    Marafini I; Laudisi F; Salvatori S; Lavigna D; Venuto C; Giannarelli D; Monteleone G
    Dig Liver Dis; 2024 Jan; 56(1):55-60. PubMed ID: 37407314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of Anti-Citrullinated Protein Antibodies and Rheumatoid Factor, Including IgA Isotypes, and Articular Manifestations in Ulcerative Colitis and Crohn's Disease.
    Janssen KMJ; Hop H; Vissink A; Dijkstra G; de Smit MJ; Brouwer E; Westra J
    Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33139618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
    Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
    J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.
    Horton N; Wu X; Philpott J; Garber A; Achkar JP; Brzezinski A; Lashner BA; Shen B
    Dig Dis Sci; 2016 Nov; 61(11):3270-3277. PubMed ID: 27619393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
    Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
    Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PR3-ANCA and panel diagnostics in pediatric inflammatory bowel disease to distinguish ulcerative colitis from Crohn's disease.
    Horn MP; Peter AM; Righini Grunder F; Leichtle AB; Spalinger J; Schibli S; Sokollik C
    PLoS One; 2018; 13(12):e0208974. PubMed ID: 30557305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against malondialdehyde-acetaldehyde adducts can help identify patients with abdominal aortic aneurysm.
    Carson JS; Xiong W; Dale M; Yu F; Duryee MJ; Anderson DR; Thiele GM; Baxter BT
    J Vasc Surg; 2016 Feb; 63(2):477-84. PubMed ID: 25724613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological markers predict inflammatory bowel disease years before the diagnosis.
    van Schaik FD; Oldenburg B; Hart AR; Siersema PD; Lindgren S; Grip O; Teucher B; Kaaks R; Bergmann MM; Boeing H; Carbonnel F; Jantchou P; Boutron-Ruault MC; Tjønneland A; Olsen A; Crowe FL; Peeters PH; van Oijen MG; Bueno-de-Mesquita HB
    Gut; 2013 May; 62(5):683-8. PubMed ID: 22842615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients.
    Plevy S; Silverberg MS; Lockton S; Stockfisch T; Croner L; Stachelski J; Brown M; Triggs C; Chuang E; Princen F; Singh S
    Inflamm Bowel Dis; 2013 May; 19(6):1139-48. PubMed ID: 23518807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome.
    Trbojević Akmačić I; Ventham NT; Theodoratou E; Vučković F; Kennedy NA; Krištić J; Nimmo ER; Kalla R; Drummond H; Štambuk J; Dunlop MG; Novokmet M; Aulchenko Y; Gornik O; Campbell H; Pučić Baković M; Satsangi J; Lauc G;
    Inflamm Bowel Dis; 2015 Jun; 21(6):1237-47. PubMed ID: 25895110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
    Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
    World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.